4H-Palmatine N-oxide
From DrugPedia: A Wikipedia for Drug discovery
| 4H-Palmatine N-oxide
| |
| Systematic (IUPAC) name | |
| 2,3,9,10-tetramethoxy-7-oxido-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinolin-7-ium | |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C21H25NO5 |
| Mol. mass | 371.4269 |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
[edit] Description
[edit] General Properties
*Molecular Weight
371.4269
*Molecular Formula
C21H25NO5
*IUPAC NAME
2,3,9,10-tetramethoxy-7-oxido-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinolin-7-ium
*Canonical Smiles
COC1=C(C2=C(CC3C4=CC(=C(C=C4CC[N+]3(C2)[O-])OC)OC)C=C1)OC
*Isomeric Smiles
N/A
*XLogP
1.2
*Topological Polar Surface Area
60
